X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Health & Nutrition

DSM invests to increase global Dyneema® production capacity

Content Team by Content Team
14th May 2018
in Health & Nutrition

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Royal DSM, a global science-based company active in health, nutrition, materials, announced to increase its production capacity for Dyneema®, the world’s strongest fiber™. Strong demand for both Dyneema UD (Uni-Directional laminate) and Dyneema fiber is prompting this increase. Financial details will not be disclosed.

The company is investing to install additional new UD technology at its plant in Heerlen, the Netherlands, and its plant in Greenville, NC, U.S. and will also make improvements to existing production lines to expand Dyneema UD and Dyneema fiber capacity, incorporating the latest technologies. The global production capacity of Dyneema UD will be increased by more than 20%. This capacity increase will further strengthen DSM’s product leadership under the Dyneema brand.

The capacity expansion will enable DSM to serve the growing global customer demand. The growing domestic U.S. market will be served better from DSM’s Greenville, N.C. facility. Globally-recognized law enforcement organizations such as: the New York Police Department (NYPD), U.S. Department of Homeland Security, U.S. Immigration and Customs Enforcement, Los Angeles Police Department, and many others are protected daily by Dyneema technology. The additional Dyneema UD and Dyneema fiber capacity will become available in the course of 2018 and is due be fully on stream by Q1 2019.

In addition to expanding capacity, DSM Dyneema will also further improve its carbon footprint, delivering on its brand promise Dyneema®, the Greenest Strength™. Applications made with Dyneema already deliver the lowest carbon footprint for the performance specified from cradle-to-grave compared to other materials and DSM is committed to further improve this. As an example, DSM’s plant in Greenville, North Carolina, already uses 100% renewable electricity.

Dyneema UD is a composite unidirectional laminate that offers excellent energy absorption and enhanced protection. It is available as a hard and soft ballistic material. Ongoing innovation by DSM will continue to newer, lighter, better performing materials to the market in the years ahead.

“Dyneema products are finding use in a broad and ever-increasing range of markets and applications in which lightweight strength is of the essence, for instance best-in-class protective ballistic vests, inserts and helmets,” notes DSM Dyneema President Wilfrid Gambade. “DSM Dyneema is the world’s largest UHMwPE fiber and UD manufacturer with a backward integration into UHMwPE polymer production. These investments will enable us to better accommodate growing customer demand and needs while further extending our global leadership position.”

Previous Post

Sumitomo Dainippon Pharma Announces Joint Research Agreement with MMV for Identification of Antimalarial Candidate Compounds

Next Post

Boehringer Ingelheim inaugurates its new integrated Asian Veterinary Research & Development Centre

Related Posts

Health & Nutrition

Vitafoods India 2025 Ignites Powerful Knowledge Exchange, Elevating the Future of Nutraceuticals

7th February 2025
Danone Ltd invests €100m in specialized nutrition in China
Health & Nutrition

Advancing Medical Nutrition: Hologram Sciences Announces collaboration with Mayo Clinic to Develop Precision Nutrition Platform

13th February 2024
Danone partners with digital oncology company Resilience for better nutritional care for patients with cancer
Health & Nutrition

Danone partners with digital oncology company Resilience for better nutritional care for patients with cancer

13th January 2024
Komodo Health Collaborates With Robert Wood Johnson Foundation To Advance New Research on Diet and Health
Health & Nutrition

Komodo Health Collaborates With Robert Wood Johnson Foundation To Advance New Research on Diet and Health

13th January 2024
Rheonix Inc Publishes Cyclospora cayetanensis Data in Collaboration With FDA Center for Food Safety and Applied Nutrition
Health & Nutrition

Rheonix Inc Publishes Cyclospora cayetanensis Data in Collaboration With FDA Center for Food Safety and Applied Nutrition

13th January 2024
Nestle unveils science-backed innovation for early-life nutrition
Health & Nutrition

Nestle unveils science-backed innovation for early-life nutrition

13th January 2024
Next Post

Boehringer Ingelheim inaugurates its new integrated Asian Veterinary Research & Development Centre

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In